↓ Skip to main content

Assessing the clinical utility of genetic risk scores for targeted cancer screening

Overview of attention for article published in Journal of Translational Medicine, January 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Assessing the clinical utility of genetic risk scores for targeted cancer screening
Published in
Journal of Translational Medicine, January 2021
DOI 10.1186/s12967-020-02699-w
Pubmed ID
Authors

Carly A. Conran, Zhuqing Shi, William Kyle Resurreccion, Rong Na, Brian T. Helfand, Elena Genova, Siqun Lilly Zheng, Charles B. Brendler, Jianfeng Xu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 21%
Other 4 12%
Student > Doctoral Student 3 9%
Student > Bachelor 3 9%
Librarian 2 6%
Other 5 15%
Unknown 10 29%
Readers by discipline Count As %
Medicine and Dentistry 6 18%
Biochemistry, Genetics and Molecular Biology 5 15%
Nursing and Health Professions 4 12%
Unspecified 2 6%
Psychology 2 6%
Other 1 3%
Unknown 14 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 January 2021.
All research outputs
#4,725,316
of 23,275,635 outputs
Outputs from Journal of Translational Medicine
#778
of 4,104 outputs
Outputs of similar age
#129,688
of 504,129 outputs
Outputs of similar age from Journal of Translational Medicine
#21
of 88 outputs
Altmetric has tracked 23,275,635 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,104 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 504,129 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.